US pharmacies are at risk of compromising patient safety by not giving enough attention to nonsterile compounding standards (USP General Chapter <795>). With a focus on sterile compounding and hazardous drug handling, many pharmacies are unprepared for the upcoming nonsterile compounding guidelines effective from November 1, 2023. Pharmacists should assess if nonsterile compounding takes place in their facility, ensuring compliance with scope, purchase history, and dispense history. Properly equipping designated areas and equipment is crucial. Staff must be well-trained and competent in nonsterile compounding, with regular training, cleaning, and documentation to meet the new standards. Terlumina operationalizes the assessments needed and helps pharmacies achieve compliance for success in meeting these newest USP standards. Stay updated here!
